https://theracryf.com/evg-post-agm-presentation/ 2022-07-22T08:29:12+00:00 https://theracryf.com/interim-results-2022-23/ 2022-12-09T10:21:39+00:00 https://theracryf.com/evgen-pharma-cash-runway-in-pretty-good-shape/ 2022-12-13T08:40:12+00:00 https://theracryf.com/evgen-pharma-presents-2022-clinical-trials-plans-and-progress-with-us-and-uk-regulators/ 2024-10-21T13:01:19+00:00 https://theracryf.com/evgen-pharma-talks-through-clinical-milestones-and-financial-results-from-its-2022-full-year-report/ 2024-10-21T13:02:57+00:00 https://theracryf.com/evgen-pharma-investormeet-presentation/ 2024-10-21T13:39:22+00:00 https://theracryf.com/evgen-pharma-very-busy-at-start-of-exciting-year/ 2024-10-22T08:58:17+00:00 https://theracryf.com/evgen-pharma-delighted-with-cash-position-after-promising-first-half/ 2024-10-22T09:00:33+00:00 https://theracryf.com/evgen-pharma-cmo-highlights-very-aggressive-disease-on-glioblastoma-awareness-day/ 2024-10-22T09:02:43+00:00 https://theracryf.com/evgen-pharma-have-many-shots-at-goal-solving-unmet-needs-in-the-pharmaceutical-industry/ 2024-10-22T09:11:29+00:00 https://theracryf.com/investor-meet-company-presentation/ 2024-10-22T09:12:54+00:00 https://theracryf.com/theracryf-plc-full-year-results/ 2024-10-22T09:14:41+00:00 https://theracryf.com/evgen-portfolio-update-on-core-field-of-cancer-the-rd-is-entirely-on-plan-and-on-budget/ 2024-10-22T09:16:22+00:00 https://theracryf.com/evgen-pharma-updates-on-the-star-trial-for-covid-19-glioma-research-and-key-breast-cancer-drug/ 2024-10-22T09:17:42+00:00 https://theracryf.com/investor-meet-presentation-proposed-acquisition-of-chronos-therapeutics-ltd-placing-and-accompanying-retail-offer/ 2024-10-22T09:19:53+00:00 https://theracryf.com/theracryf-plc-research-and-development-update/ 2024-10-22T09:21:12+00:00 https://theracryf.com/investor-meet-company-presentation-results-and-agm/ 2024-10-22T10:46:33+00:00 https://theracryf.com/evgen-pharma-presents-at-the-proactive-one2one-investor-forum/ 2024-10-22T13:04:08+00:00 https://theracryf.com/theracryf-plc-half-year-results-2024/ 2024-11-28T20:30:20+00:00 https://theracryf.com/theracryf-plc-investor-webinar/ 2025-04-04T08:27:25+00:00 https://theracryf.com/investor-meet-company-presentation-full-year-results-2025/ 2025-06-05T15:15:25+00:00 https://theracryf.com/ox-1-a-deep-dive-into-theracryfs-addiction-programme/ 2025-06-11T16:30:44+00:00 https://theracryf.com/theracryf-plc-post-agm-presentation/ 2025-07-10T15:55:43+00:00 https://theracryf.com/theracryf-plc-sharesoc-seminar/ 2025-12-03T12:07:44+00:00 https://theracryf.com/theracryf-plc-half-year-results-to-30-september-2025/ 2025-12-03T14:51:01+00:00 https://theracryf.com/turner-pope-webinar/ 2026-01-13T16:53:53+00:00 https://theracryf.com/investor-meet-company-investor-update/ 2026-04-24T15:27:08+00:00 https://theracryf.com/focus-ir-interview-positive-ox-1-toxicology-results-partner-interest-human-trials/ 2026-05-15T10:31:40+00:00 https://theracryf.com/advfn-interview-theracryf-strengthens-ox-1s-path-to-market-with-patent-expansion-and-scalable-manufacturing-breakthroughs/ 2026-05-21T10:34:53+00:00